Home » Topics » BioWorld Science

BioWorld Science
RSS

Genmab presents preclinical data for DuoBody-CD3xB7H4 (GEN-1047)

Nov. 29, 2021

Novel silicon-containing cannabinoids show therapeutic efficacy in model of multiple sclerosis

Nov. 29, 2021

M-9657 shows mesothelin-dependent antitumoral activity in vivo

Nov. 29, 2021

Discovery of the novel BCL6 BTB-specific inhibitor, AP-4-287

Nov. 29, 2021

Targeting senescent cells may fight insulin resistance

Nov. 29, 2021

KCC2 shows promise as therapeutic target for neonatal seizures

Nov. 29, 2021

Bristol Myers Squibb presents Gal-3 inhibitors

Nov. 29, 2021

Takeda Pharmaceutical identifies new 5-HT4 receptor agonists

Nov. 29, 2021

Merck & Co. synthesizes new LAAO inhibitors

Nov. 29, 2021

U.S. researchers patent TREM2 agonists

Nov. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...